Abbott
Ruth (Pui) Balerno is a seasoned professional in regulatory affairs with extensive experience in the medical and healthcare sectors. Ruth has held prominent roles, including Director of Regulatory Affairs at Abbott and Regulatory Affairs Director at Menarini Silicon Biosystems. Previous positions include Associate Director of Regulatory Affairs at Abbott Point of Care, Regulatory Affairs Manager at KaVo Kerr, and Regulatory Affairs Specialist at Danaher - Imaging Sciences. Ruth holds a Master of Science in Regulatory Affairs for Drugs from Northeastern University and a Bachelor of Arts in Exercise and Sports Science from the University of North Carolina at Chapel Hill.
This person is not in any offices
Abbott
372 followers
Abbott is a healthcare company that develops products to improve quality of life at all stages. Abbott’s portfolio includes diagnostics, medical devices, nutritionals and branded generic medicines. They have over 110,000 employees globally with customers in over 160 countries worldwide. With 130 years of history, Abbott is an established presence in the healthcare industry. Abbott’s portfolio has products targeted towards several categories, including cardiovascular, diabetes care, diagnostics, neuromodulation, nutrition, and medicines. Some of Abbott’s best known brands include: Similac, a line of infant formulas; EleCare, a nutritionally complete, amino acid-based medical good and infant formula with iron; PediaSure, balanced nutrition for kids on the go; Pedialyte, a formulation to prevent dehydration by restoring lost minerals and nutrients; Ensure, a line of nutrition products supporting active lifestyles; FreeStyle, a glucose monitor to make managing diabetes easier and more convenient; FreeStyle Libre, a handheld reader with a small sensor that continuously monitors glucose levels, eliminating routine finger sticks; and Glucerna, specialized nutrition to help maintain health blood glucose levels and manage diabetes.